Skip to main content
×
Home
    • Aa
    • Aa
  • Get access
    Check if you have access via personal or institutional login
  • Cited by 311
  • Cited by
    This article has been cited by the following publications. This list is generated based on data provided by CrossRef.

    Bekkat-Berkani, Rafik Ray, Riju Jain, Varsha K Chandrasekaran, Vijayalakshmi and Innis, Bruce L 2016. Evidence update: GlaxoSmithKline’s inactivated quadrivalent influenza vaccines. Expert Review of Vaccines, Vol. 15, Issue. 2, p. 201.


    Eagan, T.M. Hardie, J.A. Jul-Larsen, Å. Grydeland, T.B. Bakke, P.S. and Cox, R.J. 2016. Self-reported influenza vaccination and protective serum antibody titers in a cohort of COPD patients. Respiratory Medicine, Vol. 115, p. 53.


    Feldstein, Leora R. Matrajt, Laura Elizabeth Halloran, M. Keitel, Wendy A. and Longini, Ira M. 2016. Extrapolating theoretical efficacy of inactivated influenza A/H5N1 virus vaccine from human immunogenicity studies. Vaccine, Vol. 34, Issue. 33, p. 3796.


    Héquet, Delphine Pascual, Manuel Lartey, Sarah Pathirana, Rishi D. Bredholt, Geir Hoschler, Katja Hullin, Roger Meylan, Pascal Cox, Rebecca J. and Manuel, Oriol 2016. Humoral, T-cell and B-cell immune responses to seasonal influenza vaccine in solid organ transplant recipients receiving anti-T cell therapies. Vaccine, Vol. 34, Issue. 31, p. 3576.


    Iwasaki, Akiko 2016. Exploiting Mucosal Immunity for Antiviral Vaccines. Annual Review of Immunology, Vol. 34, Issue. 1, p. 575.


    Jamshed, Saad Walsh, Edward E. Dimitroff, Lynda J. Santelli, Jeanine Seguin and Falsey, Ann R. 2016. Improved immunogenicity of high-dose influenza vaccine compared to standard-dose influenza vaccine in adult oncology patients younger than 65 years receiving chemotherapy: A pilot randomized clinical trial. Vaccine, Vol. 34, Issue. 5, p. 630.


    Jegaskanda, Sinthujan Luke, Catherine Hickman, Heather D. Sangster, Mark Y. Wieland-Alter, Wendy F. McBride, Jacqueline M. Yewdell, Jon W. Wright, Peter F. Treanor, John Rosenberger, Carrie M. and Subbarao, Kanta 2016. Generation and Protective Ability of Influenza Virus–Specific Antibody-Dependent Cellular Cytotoxicity in Humans Elicited by Vaccination, Natural Infection, and Experimental Challenge. Journal of Infectious Diseases, p. jiw262.


    Mbawuike, Innocent N. Atmar, Robert L. Patel, Shital M. Corry, David B. Winokur, Patricia L. Brady, Rebecca C. Chen, Wilbur H. Edwards, Kathryn M. Creech, C. Buddy Walter, Emmanuel B. Frey, Sharon E. Belshe, Robert B. Goll, Johannes B. Hill, Heather and Keitel, Wendy A. 2016. Cell mediated immune responses following revaccination with an influenza A/H5N1 vaccine. Vaccine, Vol. 34, Issue. 4, p. 547.


    Miller, Ryan M. Rohde, Kalynn A. Tingle, Michael T.A. Moran, John J.M. and Hayney, Mary S. 2016. Antibody responses to influenza vaccine in pre- and post-lung transplant patients. Clinical Transplantation, Vol. 30, Issue. 5, p. 606.


    Moa, Aye M. Chughtai, Abrar A. Muscatello, David J. Turner, Robin M. and MacIntyre, C. Raina 2016. Immunogenicity and safety of inactivated quadrivalent influenza vaccine in adults: A systematic review and meta-analysis of randomised controlled trials. Vaccine, Vol. 34, Issue. 35, p. 4092.


    Mutsaerts, Eleonora Madhi, Shabir A. Cutland, Clare L. Jones, Stephanie Hugo, Andrea Trenor, Siobhan Treurnicht, Florette K. Klipstein-Grobusch, Kerstin Weinberg, Adriana and Nunes, Marta C. 2016. Influenza vaccination of pregnant women protects them over two consecutive influenza seasons in a randomized controlled trial. Expert Review of Vaccines, Vol. 15, Issue. 8, p. 1055.


    Petrie, Joshua G. Ohmit, Suzanne E. Truscon, Rachel Johnson, Emileigh Braun, Thomas M. Levine, Min Z. Eichelberger, Maryna C. and Monto, Arnold S. 2016. Modest Waning of Influenza Vaccine Efficacy and Antibody Titers During the 2007–2008 Influenza Season. Journal of Infectious Diseases, p. jiw105.


    Savic, Miloje Dembinski, Jennifer L. Kim, Yohan Tunheim, Gro Cox, Rebecca J. Oftung, Fredrik Peters, Bjoern and Mjaaland, Siri 2016. Epitope specific T-cell responses against influenza A in a healthy population. Immunology, Vol. 147, Issue. 2, p. 165.


    Scallan, Ciaran D. Lindbloom, Jonathan D. and Tucker, Sean N. 2016. Oral Modeling of an Adenovirus-Based Quadrivalent Influenza Vaccine in Ferrets and Mice. Infectious Diseases and Therapy, Vol. 5, Issue. 2, p. 165.


    Sheets, Rebecca L. Fritzell, Bernard and Aguado de Ros, M. Teresa 2016. Human challenge trials in vaccine development: Strasbourg, September 29 – October 1, 2014. Biologicals, Vol. 44, Issue. 1, p. 37.


    Sridhar, Saranya 2016. Heterosubtypic T-Cell Immunity to Influenza in Humans: Challenges for Universal T-Cell Influenza Vaccines. Frontiers in Immunology, Vol. 7,


    SULLIVAN, S. G. CARVILLE, K. S. CHILVER, M. FIELDING, J. E. GRANT, K. A. KELLY, H. LEVY, A. STOCKS, N. P. TEMPONE, S. S. and REGAN, A. K. 2016. Pooled influenza vaccine effectiveness estimates for Australia, 2012–2014. Epidemiology and Infection, Vol. 144, Issue. 11, p. 2317.


    Trombetta, Claudia Maria and Montomoli, Emanuele 2016. Influenza immunology evaluation and correlates of protection: a focus on vaccines. Expert Review of Vaccines, Vol. 15, Issue. 8, p. 967.


    Tsang, Tim K. Lau, Lincoln L.H. Cauchemez, Simon and Cowling, Benjamin J. 2016. Household Transmission of Influenza Virus. Trends in Microbiology, Vol. 24, Issue. 2, p. 123.


    Wijnans, Leonoor and Voordouw, Bettie 2016. A review of the changes to the licensing of influenza vaccines in Europe. Influenza and Other Respiratory Viruses, Vol. 10, Issue. 1, p. 2.


    ×

The role of serum haemagglutination-inhibiting antibody in protection against challenge infection with influenza A2 and B viruses

  • D. Hobson (a1), R. L. Curry (a1), A. S. Beare (a2) and A. Ward-Gardner (a3)
  • DOI: http://dx.doi.org/10.1017/S0022172400022610
  • Published online: 01 May 2009
Abstract
SUMMARY

The intranasal inoculation of volunteers with living partially attenuated strains of influenza A and B viruses offers a new opportunity to determine the protective effect of serum haemagglutin-inhibiting antibody against a strictly homologous virus, under conditions where the time and dosage of the infective challenge can be controlled, the scoring of proven infections can be more precise and higher rates of infection can be achieved than in most natural epidemics.

In 1032 adult volunteers, whose serum HI antibody titre was determined immediately before virus challenge, there was a consistent inverse quantitative relationship between the HI titre and the likelihood of infection. The PD50 (50 % protective dose) of HI antibody was 1/18–1/36, but an unusual finding was that volunteers with no detectable pre-challenge antibody often seem to be less susceptible to infection than those with pre-challenge antibody in low titre.

In one group of volunteers challenged with an influenza B strain there was no evidence that pre-challenge antibody titres against viral neuraminidase had any significant protective effect against challenge infection.

Copyright
Linked references
Hide All

This list contains references from the content that can be linked to their source. For a full set of references and notes please see the PDF or HTML where available.

A. C. Allison (1965). Genetic factors in resistance against virus infections. Archiv für die gesamte Virusforschung 17, 280.

W. J. Bashe , H. Stegmuller , D. Leonida & P. Greenwald (1964). Failure of polyvalent vaccine to provide clinical protection against Asian influenza. New England Journal of Medicine 270, 870.

B. Easterday , W. G. Laver , H. G. Pereira & G. C. Schild (1969). Antigenic composition of recombinant virus strains produced from human and avian influenza viruses. Journal of General Virology 5, 83.

L. Hoyle (1968). The Influenza Viruses, chap. 27. Vienna: Springer-Verlag.

W. G. Laver (1963). The structure of influenza viruses. 3. Disruption of the virus particle and separation of neuraminidase activity. Virology 20, 251.

Recommend this journal

Email your librarian or administrator to recommend adding this journal to your organisation's collection.

Epidemiology & Infection
  • ISSN: 0950-2688
  • EISSN: 1469-4409
  • URL: /core/journals/epidemiology-and-infection
Please enter your name
Please enter a valid email address
Who would you like to send this to? *
×